Managing residual risk after myocardial infarction among individuals with low cholesterol levels

Lisandro D Colantonio1, Vera Bittner2

  • 1Department of Epidemiology, University of Alabama at Birmingham, 1530 3rd Avenue South, RPHB 217C, Birmingham, AL 35294, USA.

Cardiology Clinics
|May 6, 2015
PubMed

Insights

Many acute myocardial infarction patients have low LDL cholesterol but still face recurrent event risk. This review covers management strategies for this high-risk group, addressing atherosclerosis, dyslipidemia, and therapy adherence.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • A significant proportion of acute myocardial infarction (AMI) patients present with low-density lipoprotein cholesterol (LDL-C) levels below 100 mg/dL.
  • Despite achieving target LDL-C, these individuals remain at substantial risk for recurrent cardiovascular events.

Purpose of the Study:

  • To review and outline management strategies for high-risk AMI patients with residual cardiovascular risk.
  • To address the multifaceted nature of residual risk in AMI survivors.

Main Methods:

  • Review of current literature on residual risk factors and management in acute myocardial infarction.
  • Synthesis of evidence regarding atherosclerosis burden, dyslipidemia, nonlipid risk factors, and therapeutic adherence.

Main Results:

  • Residual risk in AMI is multifactorial, influenced by factors beyond LDL-C levels.
  • Key contributors include the extent of atherosclerosis, persistent dyslipidemia, nonlipid risk factors, and suboptimal therapy implementation.

Conclusions:

  • Effective management requires a comprehensive approach addressing all identified risk factors.
  • Optimizing lifestyle and pharmacologic therapies is crucial for mitigating recurrent event risk in this population.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.0K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
871
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.7K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K